Related Experiment Video
Updated: May 1, 2026
11:17
Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
18.7K
Adherence to growth hormone therapy: a practical approach
M Bozzola1, S Pagani, L Iughetti
1Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Hormone Research in Paediatrics
|April 10, 2014
Summary
Early detection of poor adherence to growth hormone (GH) therapy is vital for growth hormone-deficient (GHD) patients. Regular patient interviews are essential for improving adherence and ensuring effective communication.
Area of Science:
- Pediatric Endocrinology
- Growth Hormone Therapy
- Patient Adherence
Background:
- Growth hormone (GH) deficiency (GHD) requires timely intervention to ensure normal final height.
- Monitoring adherence to GH therapy is critical for treatment success in children.
Purpose of the Study:
- To investigate the challenges in detecting and managing poor adherence to GH therapy in GHD patients.
- To identify strategies for improving patient and parent communication regarding GH treatment.
Main Methods:
- Study included 106 children with GHD (short stature, delayed bone age).
- GH therapy administered via daily subcutaneous injections.
- Adherence assessed through clinical monitoring and patient reporting.
Main Results:
- Poor adherence was suspected in several patients, with 4 cases clearly demonstrating reduced height velocity despite treatment.
- Confirmed non-adherence correlated with poor therapeutic response.
- Clinical and anthropometric data indicated the impact of non-adherence.
Conclusions:
- Regular, non-aggressive interviews with patients and parents are crucial for effective communication.
- Proactive communication strategies can help improve adherence to GH therapy in GHD patients.
Related Concept Videos
01:15Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
01:16Insulin: Dosing Regimen and Adverse Effects
1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
01:11Healing I: Introduction
14
Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
14
01:27Hormones of the Pituitary Gland
14.2K
The small, pea-sized pituitary gland is located at the base of the brain. It is crucial in regulating various bodily functions, from growth to reproduction. The gland is divided into the anterior lobe and the posterior lobe. The secretory cell clusters in the pars distalis of the anterior pituitary lobe are controlled by hypothalamic regulators and synthesize six primary hormones.
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
14.2K
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:26Cellular Adaptation II: Hypertrophy
54
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
54